The silencing of LncRNA AFAP1-AS1 could reduce FKBP1A expression through miR-195-5p, thereby improving paclitaxel tolerance in PTX-resistant prostate cancer cells [15]. The gene discussed is AFAP1; the disease is prostate cancer.